How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
38
RVP Quote, Financials, Valuation and Earnings
Last price:
$0.70
Seasonality move
:
14.31%
Day range:
$0.69 - $0.73
52-week range:
$0.56 - $1.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.63x
P/B ratio:
0.24x
Volume:
32.7K
Avg. volume:
35.4K
1-year change:
-33.18%
Market cap:
$20.7M
Revenue:
$33M
EPS (TTM):
-$0.54
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Retractable Technologies has -- downside to fair value with a price target of -- per share.
RVP vs. S&P 500
-
Over the past 5 trading days, Retractable Technologies has overperformed the S&P 500 by 3.8% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Retractable Technologies does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Retractable Technologies revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Retractable Technologies reported revenues of $10.3M.
Earnings Growth
-
Retractable Technologies earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Retractable Technologies reported earnings per share of -$0.07.
Enterprise value:
-22.4M
EV / Invested capital:
--
Price / LTM sales:
0.63x
EV / EBIT:
--
EV / Revenue:
-0.68x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
1.73x
Price / Operating cash flow:
6.47x
Enterprise value / EBITDA:
-5.38x
Gross Profit (TTM):
$3M
Return On Assets:
-9.19%
Net Income Margin (TTM):
-41.11%
Return On Equity:
-16.83%
Return On Invested Capital:
-16.57%
Operating Margin:
-49.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $94.8M | $43.6M | $33M | $14.3M | $9.1M | |
| Gross Profit | $28.3M | $9.1M | -$1M | $1.5M | -$2.5M | |
| Operating Income | $3M | -$2.2M | -$12.2M | $3.4M | -$1.3M | |
| EBITDA | $9.9M | -$1.2M | $4.2M | $1.7M | $5.7M | |
| Diluted EPS | $0.15 | -$0.24 | -$0.41 | -- | $0.13 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $69.5M | $104.5M | $88.8M | $77.6M | $73.3M | |
| Total Assets | $105M | $206.3M | $195.7M | $179.7M | $160.7M | |
| Current Liabilities | $27.9M | $35.3M | $12.1M | $9.4M | $8.8M | |
| Total Liabilities | $55.1M | $107.1M | $89.1M | $80.4M | $73.6M | |
| Total Equity | $49.9M | $99.2M | $106.5M | $99.3M | $87.2M | |
| Total Debt | $3.7M | $2.1M | $1.8M | $1.5M | $1.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $16.8M | $2.8M | -$11.6M | $1.9M | -$1.1M | |
| Cash From Investing | -$31.2M | -$10.8M | $3.7M | -$347.8K | $1.6M | |
| Cash From Financing | $5M | $941.6K | -$535.4K | -$136.4K | -$137K | |
| Free Cash Flow | -$61.9K | $1.9M | -$13M | $1.7M | -$1.4M | |
RVP
Sector
Market Cap
$20.7M
$34.2M
Price % of 52-Week High
56.56%
42.23%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-34.91%
-41.76%
Beta (5-Year)
2.279
0.737
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-1.47%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.70
200-day SMA
Sell
Level
$0.81
Bollinger Bands (100)
Sell
Level
0.66 - 0.8
Chaikin Money Flow
Buy
Level
10.9M
20-day SMA
Buy
Level
$0.71
Relative Strength Index (RSI14)
Sell
Level
49.93
ADX Line
Sell
Level
21.05
Williams %R
Neutral
Level
-64.6018
50-day SMA
Sell
Level
$0.75
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
99.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0197)
Buy
CA Score
(Annual)
Level (-0.2602)
Buy
Beneish M-Score
(Annual)
Level (-7.274)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.4382)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company’s other products.
Stock Forecast FAQ
In the current month, RVP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RVP average analyst price target in the past 3 months is --.
-
Where Will Retractable Technologies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Retractable Technologies share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Retractable Technologies?
Analysts are divided on their view about Retractable Technologies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Retractable Technologies is a Sell and believe this share price will rise from its current level to --.
-
What Is Retractable Technologies's Price Target?
The price target for Retractable Technologies over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RVP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Retractable Technologies is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RVP?
You can purchase shares of Retractable Technologies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Retractable Technologies shares.
-
What Is The Retractable Technologies Share Price Today?
Retractable Technologies was last trading at $0.70 per share. This represents the most recent stock quote for Retractable Technologies. Yesterday, Retractable Technologies closed at $0.72 per share.
-
How To Buy Retractable Technologies Stock Online?
In order to purchase Retractable Technologies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 13.86% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is up 13.26% over the past day.
Sell
38
NOC alert for Apr 23
Northrop Grumman [NOC] is down 12.3% over the past day.
